Table 1 Baseline demographic and clinical characteristics of the participants
Characteristics | Quartiles of TG/HDL-C Ratio | P value | |||
|---|---|---|---|---|---|
Q1 (≤0.46) | Q2 (0.47–0.63) | Q3 (0.64–0.86) | Q4 (≥0.87) | ||
Age (years) | 41.7 ± 14.3 | 42.5 ± 14.8 | 42.7 ± 14.8 | 43.0 ± 14.9 | 0.010 |
Gender, male/female (n) | 1188/1340 | 1247/1172 | 1278/1184 | 1344/1085 | < 0.001 |
Body mass index (kg/m2) | 20.3 ± 1.9 | 20.8 ± 2.0 | 21.3 ± 2.0 | 21.8 ± 2.0 | < 0.001 |
Systolic blood pressure (mm Hg) | 114.0 ± 14.8 | 116.6 ± 15.9 | 119.8 ± 16.5 | 122.0 ± 16.0 | < 0.001 |
Diastolic blood pressure (mm Hg) | 69.0 ± 9.3 | 70.5 ± 9.9 | 72.1 ± 10.0 | 73.6 ± 10.1 | < 0.001 |
Fasting plasma glucose (mmol/L) | 4.94 ± 0.59 | 5.05 ± 0.63 | 5.11 ± 0.64 | 5.20 ± 0.89 | < 0.001 |
Albumin (U/L) | 44.1 ± 2.7 | 44.2 ± 2.8 | 44.3 ± 2.7 | 44.5 ± 2.8 | < 0.001 |
Alanine aminotransferase (U/L) | 16.6 ± 14.2 | 17.8 ± 21.0 | 18.9 ± 12.8 | 20.6 ± 14.5 | < 0.001 |
Aspartate aminotransferase (U/L) | 21.5 ± 8.6 | 22.1 ± 10.4 | 22.4 ± 8.1 | 22.8 ± 8.8 | < 0.001 |
Alkaline phosphatase (U/L) | 63.7 ± 21.0 | 68.0 ± 20.3 | 71.8 ± 23.6 | 75.1 ± 22.9 | < 0.001 |
Gamma glutamyl transpeptidase (U/L) | 20.6 ± 20.2 | 22.3 ± 14.8 | 27.1 ± 27.4 | 29.3 ± 24.9 | < 0.001 |
Creatinine (mmol/L) | 70.7 ± 15.5 | 75.2 ± 22.9 | 79.3 ± 32.1 | 83.3 ± 26.5 | < 0.001 |
Uric acid (μmol/L) | 233.4 ± 68.3 | 253.4 ± 77.1 | 274.8 ± 79.3 | 296.1 ± 80.2 | < 0.001 |
Direct bilirubin (μmol/L) | 2.40 (1.60–2.90) | 2.38 (1.60–2.80) | 2.31 (1.50–2.80) | 2.31 (1.50–2.80) | 0.003 |
Total cholesterol (mmol/L) | 4.31 ± 0.53 | 4.31 ± 0.54 | 4.34 ± 0.55 | 4.40 ± 0.50 | < 0.001 |
Triglyceride (mmol/L) | 0.64 (0.55–0.72) | 0.85 (0.75–0.93) | 1.05 (0.93–1.16) | 1.36 (1.22–1.50) | < 0.001 |
HDL cholesterol (mmol/L) | 1.78 ± 0.29 | 1.57 ± 0.24 | 1.43 ± 0.22 | 1.26 ± 0.16 | < 0.001 |
LDL cholesterol (mmol/L) | 1.96 ± 0.39 | 2.08 ± 0.40 | 2.16 ± 0.42 | 2.27 ± 0.39 | < 0.001 |
TG/HDL-C ratio | 0.36 ± 0.07 | 0.54 ± 0.05 | 0.73 ± 0.07 | 1.08 ± 0.17 | < 0.001 |